• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸二酯酶抑制对扩张型心肌病心肌能量代谢的影响。

Influence of phosphodiesterase inhibition on myocardial energetics in dilative cardiomyopathy.

作者信息

Hasenfuss G, Holubarsch C, Heiss W H, Bonzel T, Meinertz T, Just H

机构信息

Department of Internal Medicine, University of Freiburg, F.R.G.

出版信息

Basic Res Cardiol. 1987;82 Suppl 2:403-9. doi: 10.1007/978-3-662-11289-2_39.

DOI:10.1007/978-3-662-11289-2_39
PMID:2959265
Abstract

The effects of inhibition of phosphodiesterase by enoximone on left ventricular haemodynamics and myocardial energetics were investigated in 10 patients with idiopathic dilative cardiomyopathy. After intravenous administration of enoximone, there was a significant reduction of left ventricular systolic pressure from 126 +/- 21 to 93 +/- 16 mm Hg, of left ventricular end-diastolic pressure from 16 +/- 8 to 5 +/- 3 mm Hg and of left ventricular end-diastolic volume from 287 +/- 54 to 215 +/- 69 ml. Left ventricular pressure-volume work decreased significantly from 12.1 +/- 3.6 to 7.6 +/- 2.8 mm Hg.l. Heart rate was 87 +/- 17 before and 103 +/- 18 min-1 after administration of enoximone (p less than 0.01). Left ventricular systolic stress-time integral, a major determinant of myocardial oxygen consumption, decreased by 49% from 91 +/- 32 to 46 +/- 15 10(3) dyn.s/cm2 (p less than 0.01). In contrast myocardial oxygen consumption per beat was reduced by only 18%, from 138 +/- 28 to 113 +/- 17 microliters O2/100 g (p less than 0.01). The economy of myocardial contraction as calculated by the ratio of systolic stress-time integral to myocardial oxygen consumption per beat was 675 +/- 192 before and 370 +/- 128 dyn.s.100 g/cm2.microliter O2 after administration of enoximone. In conclusion, the phosphodiesterase inhibitor enoximone exhibits vascular and myocardial effects. The myocardial effects result in decreased economy of myocardial contraction. The possible molecular mechanisms of these energetic changes are discussed.

摘要

在10例特发性扩张型心肌病患者中研究了依诺昔酮抑制磷酸二酯酶对左心室血流动力学和心肌能量代谢的影响。静脉注射依诺昔酮后,左心室收缩压从126±21显著降至93±16mmHg,左心室舒张末期压力从16±8降至5±3mmHg,左心室舒张末期容积从287±54降至215±69ml。左心室压力-容积功从12.1±3.6显著降至7.6±2.8mmHg·l。给药前心率为87±17次/分钟,给药后为103±18次/分钟(p<0.01)。心肌耗氧量的主要决定因素左心室收缩期应力-时间积分从91±32降至46±15×10³dyn·s/cm²,降低了49%(p<0.01)。相比之下,每搏心肌耗氧量仅降低了18%,从138±28降至113±17μl O₂/100g(p<0.01)。依诺昔酮给药前每搏收缩期应力-时间积分与心肌耗氧量之比计算得出的心肌收缩经济性为675±192,给药后为370±128dyn·s·100g/cm²·μl O₂。总之,磷酸二酯酶抑制剂依诺昔酮具有血管和心肌效应。心肌效应导致心肌收缩经济性降低。讨论了这些能量变化可能的分子机制。

相似文献

1
Influence of phosphodiesterase inhibition on myocardial energetics in dilative cardiomyopathy.磷酸二酯酶抑制对扩张型心肌病心肌能量代谢的影响。
Basic Res Cardiol. 1987;82 Suppl 2:403-9. doi: 10.1007/978-3-662-11289-2_39.
2
Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone.扩张型心肌病患者的心肌能量代谢。硝普钠和依诺昔酮的影响。
Circulation. 1989 Jul;80(1):51-64. doi: 10.1161/01.cir.80.1.51.
3
Influence of enoximone on myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside.依诺昔酮对特发性扩张型心肌病患者心肌能量代谢的影响:与硝普钠的比较。
J Cardiovasc Pharmacol. 1989;14 Suppl 1:S69-74.
4
Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.特发性扩张型心肌病患者静脉注射依诺昔酮后的心脏能量代谢
Am J Cardiol. 1987 Aug 14;60(5):53C-56C. doi: 10.1016/0002-9149(87)90526-1.
5
Augmentation of diastolic function with phosphodiesterase inhibition in congestive heart failure.磷酸二酯酶抑制增强充血性心力衰竭的舒张功能。
J Lab Clin Med. 1989 Sep;114(3):266-71.
6
Hemodynamics and myocardial oxygen metabolism of pulsus alternans in patients with dilative cardiomyopathy.
Clin Cardiol. 1987 May;10(5):323-7. doi: 10.1002/clc.4960100506.
7
Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy.通过评估扩张型心肌病患者的心肌能量代谢来区分血管舒张和正性肌力作用。
Basic Res Cardiol. 1989;84 Suppl 1:257-65. doi: 10.1007/BF02650365.
8
The phosphodiesterase-inhibitor enoximone--a new concept in the therapy of patients with impaired myocardial function in cardiac surgery.磷酸二酯酶抑制剂依诺昔酮——心脏手术中心肌功能受损患者治疗的新概念。
J Cardiothorac Anesth. 1989 Oct;3(5 Suppl 1):10. doi: 10.1016/0888-6296(89)90753-9.
9
Myocardial energetics in dilated cardiomyopathy.扩张型心肌病中的心肌能量学
Clin Cardiol. 1990 Sep;13(9):649-54. doi: 10.1002/clc.4960130912.
10
Diastolic function in patients with severe heart failure: comparison of the effects of enoximone and nitroprusside.重度心力衰竭患者的舒张功能:依诺昔酮与硝普钠疗效比较
Circulation. 1987 Jun;75(6):1214-21. doi: 10.1161/01.cir.75.6.1214.

引用本文的文献

1
Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failure.新型强心剂对磷酸二酯酶的抑制作用:作用机制及其在充血性心力衰竭治疗中可能的临床意义
Klin Wochenschr. 1989 Jun 15;67(12):605-15. doi: 10.1007/BF01718141.
2
Enoximone. A review of its pharmacological properties and therapeutic potential.依诺昔酮。对其药理特性及治疗潜力的综述。
Drugs. 1991 Dec;42(6):997-1017. doi: 10.2165/00003495-199142060-00008.